Arundic acid (ONO-2526) inhibits stimulated-S100B secretion in inflammatory conditions.

Neuroscience letters 2021 Apr 23

filter terms:

Astrocytes respond to injury by modifying the expression profile of several proteins, including the S100 calcium-binding protein B (S100B), assumed to be a marker as well as a mediator of brain injury. AA is an inhibitor of S100B synthesis and plays a protective role in different models of brain injury, as decreases in S100B expression cause decreases in extracellular S100B. However, S100B mRNA expression, S100B protein content and S100B secretion do not always occur in association; as such, we herein investigated the effect of AA on S100B secretion, using different approaches with three stimulating conditions for S100B secretion, namely, low potassium medium, TNF-α (in hippocampal slices) and LPS exposure (in astrocyte cultures). Our data indicate that AA directly affects S100B secretion, indicating that the extracellular levels of this astroglial protein may be mediating the action of this compound. More importantly, AA had no effect on basal S100B secretion, but inhibited stimulated S100B secretion (stimulated either by the proinflammatory molecules, LPS or TNF-α, or by low potassium medium). Data from hippocampal slices that were directly exposed to AA, or from animals that received the acid by intracerebroventricular infusion, contribute to understanding its neuroprotective effect. Copyright © 2021 Elsevier B.V. All rights reserved.

Citation

Adriana Fernanda K Vizuete, Juliana de Lima Cordeiro, Juliana Dalibor Neves, Marina Seady, Lucas Kich Grun, Florencia María Barbé-Tuana, Marina Concli Leite, Carlos Alexandre Netto, Carlos-Alberto Gonçalves. Arundic acid (ONO-2526) inhibits stimulated-S100B secretion in inflammatory conditions. Neuroscience letters. 2021 Apr 23;751:135776